News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Savara Updates Series B Funding Tranche to $14.3 Million


6/26/2013 8:43:46 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Savara Inc. has updated a previously reported tranche of Series B round financing to $14.3 million. The Austin-based company, which develops pulmonary drugs, collected the capital from 239 investors, according to a Wednesday filing with the U.S. Securities and Exchange Commission. Savara reported in March raising a $7.4 million second tranche of its funding round. The $14.3 million is in addition to an $8.6 million first tranche completed in June 2012.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
Savara
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES